Skip to main content
Top
Published in: European Radiology 12/2012

01-12-2012 | Breast

Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI

Authors: Valencia King, Yajia Gu, Jennifer B. Kaplan, Jennifer D. Brooks, Malcolm C. Pike, Elizabeth A Morris

Published in: European Radiology | Issue 12/2012

Login to get access

Abstract

Objective

To evaluate the effect of menopausal status on the background parenchymal enhancement (BPE) and amount of fibroglandular tissue (FGT) on breast MRI.

Methods

Retrospective review identified 1,130 women who underwent screening breast MRI between July and November 2010. In 28 of these women, breast MRI was performed both at one time point while pre- and one time point while post-menopausal (median interval 49 months). Two independent readers blinded to menopausal status used categorical scales to rate BPE (minimal/mild/moderate/marked) and FGT (fatty/scattered/heterogeneously dense/dense). Consensus was reached when there was disagreement. The sign test was used to assess changes in rating categories, and the Spearman rank and Fisher’s exact tests were used to measure correlations and associations between variables.

Results

Significant proportions of women demonstrated decreases in BPE and FGT on post-menopausal breast MRI (P = 0.0001 and P = 0.0009). BPE category was unchanged in 39 % (11/28) and decreased in 61 % (17/28) of women. FGT category was unchanged in 61 % (17/28) and decreased in 39 % (11/28) of women. Age, reason for menopause, or interval between MRIs had no significant impact on changes in BPE and FGT.

Conclusion

On MRI, BPE, and FGT decrease after menopause in significant proportions of women; BPE decreases more than FGT.

Key Points

• On MRI, background parenchymal enhancement and fibroglandular tissue both decrease after menopause.
• The reduced postmenopausal enhancement is more marked in parenchyma than fibroglandular tissue.
• Background enhancement and fibroglandular tissue seen on MRI are under hormonal influence.
Literature
1.
go back to reference Kuhl CK, Bieling HB, Gieseke J et al (1997) Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 203:137–144PubMed Kuhl CK, Bieling HB, Gieseke J et al (1997) Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 203:137–144PubMed
2.
go back to reference Morris EA (2007) Diagnostic breast MR imaging: current status and future directions. Radiol Clin North Am 45:863–880PubMedCrossRef Morris EA (2007) Diagnostic breast MR imaging: current status and future directions. Radiol Clin North Am 45:863–880PubMedCrossRef
3.
go back to reference Muller-Schimpfle M, Ohmenhauser K, Stoll P, Dietz K, Claussen CD (1997) Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 203:145–149PubMed Muller-Schimpfle M, Ohmenhauser K, Stoll P, Dietz K, Claussen CD (1997) Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 203:145–149PubMed
4.
go back to reference Hambly NM, Liberman L, Dershaw DD, Brennan S, Morris EA (2011) Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up. AJR Am J Roentgenol 196:218–224PubMedCrossRef Hambly NM, Liberman L, Dershaw DD, Brennan S, Morris EA (2011) Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up. AJR Am J Roentgenol 196:218–224PubMedCrossRef
5.
go back to reference King V, Brooks JD, Bernstein JL, Reiner AS, Pike MC, Morris EA (2011) Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology 260:50–60PubMedCrossRef King V, Brooks JD, Bernstein JL, Reiner AS, Pike MC, Morris EA (2011) Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology 260:50–60PubMedCrossRef
6.
go back to reference Hattangadi J, Park C, Rembert J et al (2008) Breast stromal enhancement on MRI is associated with response to neoadjuvant chemotherapy. AJR Am J Roentgenol 190:1630–1636PubMedCrossRef Hattangadi J, Park C, Rembert J et al (2008) Breast stromal enhancement on MRI is associated with response to neoadjuvant chemotherapy. AJR Am J Roentgenol 190:1630–1636PubMedCrossRef
7.
go back to reference Delille JP, Slanetz PJ, Yeh ED, Kopans DB, Halpern EF, Garrido L (2005) Hormone replacement therapy in postmenopausal women: breast tissue perfusion determined with MR imaging - initial observations. Radiology 235:36–41PubMedCrossRef Delille JP, Slanetz PJ, Yeh ED, Kopans DB, Halpern EF, Garrido L (2005) Hormone replacement therapy in postmenopausal women: breast tissue perfusion determined with MR imaging - initial observations. Radiology 235:36–41PubMedCrossRef
8.
go back to reference Pfleiderer SO, Sachse S, Sauner D et al (2004) Changes in magnetic resonance mammography due to hormone replacement therapy. Breast Cancer Res 6:R232–238PubMedCrossRef Pfleiderer SO, Sachse S, Sauner D et al (2004) Changes in magnetic resonance mammography due to hormone replacement therapy. Breast Cancer Res 6:R232–238PubMedCrossRef
9.
go back to reference Eng-Wong J, Orzano-Birgani J, Chow CK et al (2008) Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer. Cancer Epidemiol Biomarkers Prev 17:1696–1701PubMedCrossRef Eng-Wong J, Orzano-Birgani J, Chow CK et al (2008) Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer. Cancer Epidemiol Biomarkers Prev 17:1696–1701PubMedCrossRef
10.
go back to reference Oksa S, Parkkola R, Luukkaala T, Maenpaa J (2009) Breast magnetic resonance imaging findings in women treated with toremifene for premenstrual mastalgia. Acta Radiol 50:984–989PubMedCrossRef Oksa S, Parkkola R, Luukkaala T, Maenpaa J (2009) Breast magnetic resonance imaging findings in women treated with toremifene for premenstrual mastalgia. Acta Radiol 50:984–989PubMedCrossRef
11.
go back to reference Sung JS, Lee CH, Morris EA, Oeffinger KC, Dershaw DD (2011) Screening breast MR imaging in women with a history of chest irradiation. Radiology 259:65–71PubMedCrossRef Sung JS, Lee CH, Morris EA, Oeffinger KC, Dershaw DD (2011) Screening breast MR imaging in women with a history of chest irradiation. Radiology 259:65–71PubMedCrossRef
12.
go back to reference American College of Radiology BI-RADS Committee (2003) Breast Imaging Reporting and Data System, 4th edn. American College of Radiology, Reston, Virginia American College of Radiology BI-RADS Committee (2003) Breast Imaging Reporting and Data System, 4th edn. American College of Radiology, Reston, Virginia
13.
go back to reference Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMedCrossRef Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMedCrossRef
14.
go back to reference Jansen SA, Lin VC, Giger ML, Li H, Karczmar GS, Newstead GM (2011) Normal parenchymal enhancement patterns in women undergoing MR screening of the breast. Eur Radiol 21:1374–1382PubMedCrossRef Jansen SA, Lin VC, Giger ML, Li H, Karczmar GS, Newstead GM (2011) Normal parenchymal enhancement patterns in women undergoing MR screening of the breast. Eur Radiol 21:1374–1382PubMedCrossRef
15.
go back to reference Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M (2002) A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 11:1048–1053PubMed Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M (2002) A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 11:1048–1053PubMed
Metadata
Title
Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI
Authors
Valencia King
Yajia Gu
Jennifer B. Kaplan
Jennifer D. Brooks
Malcolm C. Pike
Elizabeth A Morris
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
European Radiology / Issue 12/2012
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-012-2553-8

Other articles of this Issue 12/2012

European Radiology 12/2012 Go to the issue